Literature DB >> 31792128

Molecular Imaging with Reporter Genes: Has Its Promise Been Delivered?

Inna Serganova1, Ronald G Blasberg2,3,4.   

Abstract

The first reporter systems were developed in the early 1980s and were based on measuring the activity of an enzyme-as a surrogate measure of promoter-driven transcriptional activity-which is now known as a reporter gene system. The initial objective and application of reporter techniques was to analyze the activity of a specific promoter (namely, the expression of a gene that is under the regulation of the specific promoter that is linked to the reporter gene). This system allows visualization of specific promoter activity with great sensitivity. In general, there are 2 classes of reporter systems: constitutively expressed (always-on) reporter constructs used for cell tracking, and inducible reporter systems sensitive to endogenous signaling molecules and transcription factors that characterize specific tissues, tumors, or signaling pathways.This review traces the development of different reporter systems, using fluorescent and bioluminescent proteins as well as radionuclide-based reporter systems. The development and application of radionuclide-based reporter systems is the focus of this review. The question at the end of the review is whether the "promise" of reporter gene imaging has been realized. What is required for moving forward with radionuclide-based reporter systems, and what is required for successful translation to clinical applications?
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Mesh:

Year:  2019        PMID: 31792128     DOI: 10.2967/jnumed.118.220004

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

Review 1.  Synthetic biomarkers: a twenty-first century path to early cancer detection.

Authors:  Gabriel A Kwong; Sharmistha Ghosh; Lena Gamboa; Christos Patriotis; Sudhir Srivastava; Sangeeta N Bhatia
Journal:  Nat Rev Cancer       Date:  2021-09-06       Impact factor: 60.716

Review 2.  Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging.

Authors:  Peter J Gawne; Francis Man; Philip J Blower; Rafael T M de Rosales
Journal:  Chem Rev       Date:  2022-05-12       Impact factor: 72.087

3.  NRM 2021 Abstract Booklet.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2021-12       Impact factor: 6.960

4.  Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours.

Authors:  Alexandra M Mowday; Ludwig J Dubois; Aleksandra M Kubiak; Jasmine V E Chan-Hyams; Christopher P Guise; Amir Ashoorzadeh; Philippe Lambin; David F Ackerley; Jeff B Smaill; Nigel P Minton; Jan Theys; Adam V Patterson
Journal:  Cancer Gene Ther       Date:  2021-02-08       Impact factor: 5.987

Review 5.  Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors.

Authors:  Violena Pietrobon; Alessandra Cesano; Francesco Marincola; Jakob Nikolas Kather
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

Review 6.  A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy.

Authors:  Susanna C Concilio; Stephen J Russell; Kah-Whye Peng
Journal:  Mol Ther Oncolytics       Date:  2021-03-10       Impact factor: 7.200

Review 7.  Whole-Body Imaging to Assess Cell-Based Immunotherapy: Preclinical Studies with an Update on Clinical Translation.

Authors:  Noriko Sato; Peter L Choyke
Journal:  Mol Imaging Biol       Date:  2021-11-23       Impact factor: 3.488

Review 8.  MRI techniques for immunotherapy monitoring.

Authors:  Doreen Lau; Pippa G Corrie; Ferdia A Gallagher
Journal:  J Immunother Cancer       Date:  2022-09       Impact factor: 12.469

9.  E. coli nitroreductase NfsA is a reporter gene for non-invasive PET imaging in cancer gene therapy applications.

Authors:  Alexandra Marie Mowday; Janine Naomi Copp; Sophie Philippa Syddall; Ludwig Jerome Dubois; Jingli Wang; Natasja Gabi Lieuwes; Rianne Biemans; Amir Ashoorzadeh; Maria Rosaria Abbattista; Elsie May Williams; Christopher Paul Guise; Philippe Lambin; David Francis Ackerley; Jeff Bruce Smaill; Jan Theys; Adam Vorn Patterson
Journal:  Theranostics       Date:  2020-08-21       Impact factor: 11.556

Review 10.  Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy.

Authors:  Cristina Barca; Christoph M Griessinger; Andreas Faust; Dominic Depke; Markus Essler; Albert D Windhorst; Nick Devoogdt; Kevin M Brindle; Michael Schäfers; Bastian Zinnhardt; Andreas H Jacobs
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.